These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20621223)

  • 1. Monitoring of neuromuscular blockade in general anaesthesia.
    Smith A
    Lancet; 2010 Jul; 376(9735):77-9. PubMed ID: 20621223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Residual neuromuscular blockade].
    Fuchs-Buder T; Schmartz D
    Anaesthesist; 2017 Jun; 66(6):465-476. PubMed ID: 28573344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [When muscle relaxants have unexpected prolonged duration during anaesthesia].
    Madsen MV; Øberg E; Rosenberg J; Gätke MR
    Ugeskr Laeger; 2015 Nov; 177(47):V04150300. PubMed ID: 26616828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
    Martin-Flores M; Boesch J; Campoy L; Gleed RD
    J Am Anim Hosp Assoc; 2011; 47(4):294-8. PubMed ID: 21673340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neuromuscular blockade on operating conditions during general anesthesia for spinal surgery.
    Li YL; Liu YL; Xu CM; Lv XH; Wan ZH
    J Neurosurg Anesthesiol; 2014 Jan; 26(1):45-9. PubMed ID: 23887680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual neuromuscular block and adverse respiratory events.
    Kopman AF
    Anesth Analg; 2008 Nov; 107(5):1756; author reply 1756. PubMed ID: 18931246
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of nondepolarizing block: only when necessary.
    Savarese J
    Acta Anaesthesiol Scand Suppl; 1997; 110():103. PubMed ID: 9248551
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
    Carron M; Parotto E; Ori C
    Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
    [No Abstract]   [Full Text] [Related]  

  • 9. Residual paralysis: a real problem or did we invent a new disease?
    Donati F
    Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular monitoring: what evidence do we need to be convinced?
    Donati F
    Anesth Analg; 2010 Jul; 111(1):6-8. PubMed ID: 20576959
    [No Abstract]   [Full Text] [Related]  

  • 11. Can residual paralysis be avoided?: A critical appraisal of the use of sugammadex.
    Esteves S
    Eur J Anaesthesiol; 2015 Oct; 32(10):663-5. PubMed ID: 26322661
    [No Abstract]   [Full Text] [Related]  

  • 12. Research, not quality assurance.
    Anderson JR; Schonfeld T
    Anesth Analg; 2009 Jan; 108(1):376; author reply 376-7. PubMed ID: 19095878
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of neuromuscular blocking agents and reversal of blockade: guidelines from Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor].
    Alvarez Gómez JA; Ariño Irujo JJ; Errando Oyonarte CL; Matínez Torrente F; Roigé i Solé J; Gilsanz Rodríguez F;
    Rev Esp Anestesiol Reanim; 2009 Dec; 56(10):616-27. PubMed ID: 20151524
    [No Abstract]   [Full Text] [Related]  

  • 15. The undesirable effects of neuromuscular blocking drugs.
    Claudius C; Garvey LH; Viby-Mogensen J
    Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring neuromuscular block: an update.
    Fuchs-Buder T; Schreiber JU; Meistelman C
    Anaesthesia; 2009 Mar; 64 Suppl 1():82-9. PubMed ID: 19222435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient safety incidents involving neuromuscular blockade: analysis of the UK National Reporting and Learning System data from 2006 to 2008.
    Arnot-Smith J; Smith AF
    Anaesthesia; 2010 Nov; 65(11):1106-13. PubMed ID: 20840604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of neuromuscular blockade: a comparison of train-of-four and the Campbell diagram.
    Baedorf Kassis E; Train S; MacNeil B; Loring SH; Talmor D
    Intensive Care Med; 2018 Dec; 44(12):2305-2306. PubMed ID: 30350170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.